We’ve decided to exit our position in OrthoLogic Corporation (NASDAQ:CAPS) at its $0.90 close yesterday. We opened the position at $0.60, so we’re up 50% on an absolute basis… 253 more words
6 years, 5 months ago
MediciNova Inc. (NASDAQ:MNOV) will acquire Avigen Inc (NASDAQ:AVGN) for $1.24 per share in cash or secured convertible notes. While the stock is trading at a slight premium to the bid, we’re taking the opportunity to exit. 439 more words
Avigen Inc (NASDAQ:AVGN) has filed its 10Q for the period ended June 30, 2009.
One interesting aspect of the 10Q is the cost the company attributes to responding to the proxy fight and hostile tender offer: 565 more words
6 years, 6 months ago
OrthoLogic Corporation (NASDAQ:CAPS) has filed its 10Q for the quarter ended June 30, 2008.
We’ve been following CAPS (see our post archive here) because it trades below its net cash value and Biotechnology Value Fund (BVF) has a 13.42% holding. 416 more words
Avigen Inc (NASDAQ:AVGN) has been granted a United States Patent for the treatment of neuropathic pain with its AV411 (ibudilast) compound.
We started following AVGN in December last year (see archived posts… 706 more words
6 years, 8 months ago
Avigen Inc (NASDAQ:AVGN) has filed its 10Q for the period ended March 31, 2009.
We started following AVGN in December last year (see archived posts… 404 more words
6 years, 9 months ago
Neurobiological Technologies Inc (NASDAQ:NTII) has filed its 10Q for the period ended march 31, 2009. After reviewing the 10Q, we have reduced our estimate of NTII’s liquidation value to $19.6M or $0.73 per share. 322 more words